Abstract
The enzymatically derived and enantiopure cis-1,2-dihydrocatechol 1 has been converted, over 14 one-pot operations, into the (+)-form of the alkaloid narseronine (2). The present study, which complements earlier work that established a route from metabolite 1 to enantiomer (-)-2, involves an N-bromosuccinimide/tri-n-butyltin hydride-mediated cyclisation reaction to construct the unsaturated B-ring lactone of the target compound.
Original language | English |
---|---|
Pages (from-to) | 241-247 |
Number of pages | 7 |
Journal | Australian Journal of Chemistry |
Volume | 68 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2015 |